Cargando…
Minimal hepatic toxicity of Onyx-015: spatial restriction of coxsackie-adenoviral receptor in normal liver
We administered an adenoviral vector, Onyx-015, into the hepatic artery of patients with metastatic colorectal cancer involving the liver. Thirty-five patients enrolled in this multi-institutional phase I/II trial received up to eight arterial infusions of up to 2 × 10(12) viral particles. Hepatic t...
Autores principales: | Au, T, Thorne, S, Korn, W M, Sze, D, Kirn, D, Reid, T R |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group US
2006
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7091580/ https://www.ncbi.nlm.nih.gov/pubmed/17139321 http://dx.doi.org/10.1038/sj.cgt.7700988 |
Ejemplares similares
-
ONYX-015: mechanisms of action and clinical potential of a replication-selective adenovirus
por: Ries, S, et al.
Publicado: (2002) -
ZEB1 limits adenoviral infectability by transcriptionally repressing the Coxsackie virus and Adenovirus Receptor
por: Lacher, Markus D, et al.
Publicado: (2011) -
Potentiation of radiation therapy by the oncolytic adenovirus dl1520 (ONYX-015) in human malignant glioma xenografts
por: Geoerger, B, et al.
Publicado: (2003) -
Heat shock protein 72 expression allows permissive replication of oncolytic adenovirus dl1520 (ONYX-015) in rat glioblastoma cells
por: Madara, Jonathan, et al.
Publicado: (2005) -
Intravascular adenoviral agents in cancer patients: Lessons from clinical trials
por: Reid, Tony, et al.
Publicado: (2002)